Drug Shortage Report for APO-PREGABALIN
Report ID | 456 |
Drug Identification Number | 02394251 |
Brand name | APO-PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 75MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 500 BTL |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2016-09-07 |
Estimated end date | 2017-06-09 |
Actual end date | 2017-05-08 |
Shortage status | Resolved |
Updated date | 2017-05-10 |
Company comments | APO-PREGABALIN CAP 75MG 100 BTL is available |
Health Canada comments | |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.